Temsirolimus in the treatment of mantle cell lymphoma: frequency and management of adverse effects.

Abstract:

PURPOSE OF REVIEW:Temsirolimus (Torisel) is a mammalian target of rapamycin (mTOR) inhibitor approved for the treatment of relapsed/refractory mantle cell lymphoma (MCL). The recommended dosage in this indication (175 mg once weekly for 3 weeks and then 75 mg once weekly as maintenance) is higher than that for renal cell carcinoma; thus, the safety profile is quite different in the two indications. The aim of this review is to examine safety data for temsirolimus in MCL and provide guidance on the incidence and management of adverse events. Medline and EMBASE searches using the search terms 'temsirolimus' and 'mantle cell lymphoma'. FINDINGS:Four main published phase II-III clinical studies of temsirolimus in MCL were identified. Many adverse events are class-effect toxicities of mTOR inhibitors but, for others, often an accurate relationship with temsirolimus is difficult to assess with certainty. Haematological adverse events are the most frequently reported, but these are generally successfully managed by dose reductions or treatment delay. Gastrointestinal toxicity, especially diarrhoea, is a frequent and common adverse effect, but the incidence of grade 3-4 events is low. Other non-haematological toxicities include stomatological/dermatological and endocrinological adverse events. Incidence of these adverse events can be reduced by careful management and/or prevention. Grade 3 or higher pneumonitis, a known mTOR inhibitor-associated toxicity, was rarely reported in this indication, but the incidence was higher when temsirolimus was administered in combination with rituximab. Other adverse events include fatigue/asthenia, infection, hypersensitivity and extravasation. Sexual disorders, foetal malformations and psychiatric disorders are rarely reported. SUMMARY:Most temsirolimus-associated adverse events in patients with relapsed/refractory MCL are manageable, often without impacting administration of temsirolimus.

journal_name

Curr Opin Oncol

authors

Bouabdallah K,Ribrag V,Terriou L,Soria JC,Delarue R

doi

10.1097/CCO.0b013e32835de8ee

subject

Has Abstract

pub_date

2013-03-01 00:00:00

pages

S1-12

eissn

1040-8746

issn

1531-703X

pii

00001622-201303002-00001

journal_volume

25 Suppl 2

pub_type

杂志文章,评审
  • Endocrine tumors of the pancreas.

    abstract:PURPOSE OF REVIEW:Neoplasms of the endocrine pancreas, commonly referenced as pancreatic islet cell tumors, are rare, often well differentiated endocrine neoplasms, whose biology remains poorly characterized. This article reviews the current clinical management of pancreatic islet cell tumors and describes the molecula...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,收录出版,评审

    doi:10.1097/01.cco.0000198974.59239.3c

    authors: House MG,Schulick RD

    更新日期:2006-01-01 00:00:00

  • Vandetanib and the management of advanced medullary thyroid cancer.

    abstract:PURPOSE OF REVIEW:Vandetanib is a small molecule tyrosine kinase inhibitor that has been recently approved as an 'orphan drug' for the treatment of patients with unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC). RECENT FINDINGS:MTC is a neuroendocrine malignancy frequently associated with m...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32835a42b9

    authors: Campbell MJ,Seib CD,Gosnell J

    更新日期:2013-01-01 00:00:00

  • Human papillomavirus-associated anogenital neoplasia and other solid tumors in human immunodeficiency virus-infected individuals.

    abstract::The incidence and variety of solid tumors reported among human immunodeficiency virus (HIV)-infected individuals are increasing. Among the most common of these tumors are anogenital malignant and premalignant tumors associated with human papillomavirus infection. Cervical intraepithelial neoplasia is one such human pa...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199110000-00012

    authors: Palefsky JM

    更新日期:1991-10-01 00:00:00

  • The changing face of invasive fungal infections in hematopoietic cell transplant recipients.

    abstract:PURPOSE OF REVIEW:To review recent observations that describe changes in the likelihood of invasive fungal infections, shifts in types of fungal pathogens, and altered manifestations of fungal syndromes after hematopoietic cell transplantation and explore how changes in transplant practices are influencing these epidem...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000152975.65477.7c

    authors: Wingard JR

    更新日期:2005-03-01 00:00:00

  • Pediatric genitourinary tumors.

    abstract:PURPOSE OF REVIEW:To review the 2008-2009 literature on pediatric genitourinary tumors and highlight the most significant publications. RECENT FINDINGS:New techniques such as gene expression profiling, PET, nephron-sparing surgery, and stem cell transplantation are being incorporated into contemporary treatments for p...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32833841a1

    authors: McLean TW,Buckley KS

    更新日期:2010-05-01 00:00:00

  • Advances in prostate cancer.

    abstract:PURPOSE OF REVIEW:The purpose of this review is to highlight the most important developments in the diagnosis, prevention, and management of prostate cancer reported in the past year that have been published in the medical literature. RECENT FINDINGS:Recent research has yielded important insights into the effects of l...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200405000-00009

    authors: Ryan CJ,Small EJ

    更新日期:2004-05-01 00:00:00

  • Poly (ADP-ribose) polymerase inhibitors: on the horizon of tailored and personalized therapies for epithelial ovarian cancer.

    abstract:PURPOSE OF REVIEW:Management of the epithelial ovarian cancer (EOC) remains a therapeutic challenge, with continued poor overall survival (OS). Given low chemotherapy response rates for recurrent disease and short survival times, new treatment options with improved therapeutic indices for targeting cancer's vulnerabili...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3283564230

    authors: Ratner ES,Sartorelli AC,Lin ZP

    更新日期:2012-09-01 00:00:00

  • Palliative care of patients with terminal cancer.

    abstract::Palliative (terminal) care is now recognized worldwide as an important, multidisciplinary aspect of the continuing care of patients with incurable cancer. Symptom control and quality-of-life are of the essence. Various treatment methods are available, and radiotherapy and chemotherapy (used appropriately) are importan...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199307000-00006

    authors: Hancock BW,Ahmedzai S,Clark D

    更新日期:1993-07-01 00:00:00

  • Personalized cancer therapy for gastrointestinal stromal tumor: synergizing tumor genotyping with imatinib plasma levels.

    abstract:PURPOSE OF REVIEW:Imatinib has exceptional activity in controlling gastrointestinal stromal tumor (GIST) due to inhibition of the constitutively active conformation of KIT and platelet-derived growth factor-alpha (PDGFRA), which is commonly seen in this tumor. This review explores the current available data on the corr...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32833a6b8e

    authors: Marrari A,Trent JC,George S

    更新日期:2010-07-01 00:00:00

  • Defining locally advanced basal cell carcinoma and integrating smoothened inhibitors into clinical practice.

    abstract:PURPOSE OF REVIEW:We summarize the concept of a locally advanced basal cell carcinoma (laBCC) and present the current consensus definition. We also review the key pieces of primary research undertaken in the past year and how these affect the use of smoothened inhibitors in a clinical setting. RECENT FINDINGS:Medium t...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000259

    authors: Khoo AB,Ali FR,Lear JT

    更新日期:2016-03-01 00:00:00

  • The role of transoral robotic surgery in the management of oropharyngeal cancer.

    abstract:PURPOSE OF REVIEW:The rising incidence of oropharyngeal squamous cell carcinoma (OPSCC), in large part as a result of the human papillomavirus (HPV), has driven a movement for the change in the management strategies. Renewed interest in minimally invasive approaches of endoscopic head and neck surgery led to introducti...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章

    doi:10.1097/CCO.0000000000000365

    authors: Dias FL,Walder F,Leonhardt FD

    更新日期:2017-05-01 00:00:00

  • Oncogene products as therapeutic targets for cancer.

    abstract::Enormous progress has been made in the last several years in delineating signal transduction pathways associated with cell proliferation and apoptosis. The components of these pathways, which include both oncogenes and tumor suppressors, may provide viable targets for therapeutic intervention for the treatment of canc...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199701000-00015

    authors: Huang PS,Heimbrook DC

    更新日期:1997-01-01 00:00:00

  • The Ewing family of tumors and the search for the Achilles' heel.

    abstract::The ideal cancer therapy would accomodate the specific biology of a tumor and be based upon understanding the mechanisms of malignancy. This vision has been the driving force in cancer research. However, the story of success in clinical cancer management is a story of empirie largely independent from progress in basic...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199907000-00007

    authors: Kovar H,Aryee D,Zoubek A

    更新日期:1999-07-01 00:00:00

  • Germ cell cancer.

    abstract::The publication of the proceedings of Fourth Workshop on Carcinoma in situ was an impressive leap in our understanding of the interaction between prenatal and postpubertal factors in the development of germ cell cancer as well as increased insight into the molecular events that are involved in the development of these...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199905000-00017

    authors: Oliver RT

    更新日期:1999-05-01 00:00:00

  • Bcl-2 antisense therapy in hematologic malignancies.

    abstract:PURPOSE OF REVIEW:Overexpression of the Bcl-2 oncoprotein is noted in various malignant disorders. In patients with hematologic malignancies, increased production of the Bcl-2 oncoprotein is associated with chemotherapy resistance, aggressive clinical course, and poor survival. Bcl-2 is an important molecular target. D...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000142074.67968.eb

    authors: Chanan-Khan A

    更新日期:2004-11-01 00:00:00

  • Biology and therapy of mantle cell lymphoma.

    abstract:PURPOSE OF REVIEW:Mantle cell lymphoma is an aggressive non-Hodgkin's lymphoma characterized by the t(11;14) chromosomal translocation and overexpression of cyclin D1. Constituting approximately 5 to 8% of all non-Hodgkin's lymphomas, it carries the poorest prognosis among non-Hodgkin's lymphoma subtypes. Standard and ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000174039.69656.2b

    authors: Williams ME,Densmore JJ

    更新日期:2005-09-01 00:00:00

  • The role of radiation in retroperitoneal sarcomas: a surgical perspective.

    abstract:PURPOSE OF REVIEW:This review focuses on the current concepts relating to the use of radiation therapy in the care of surgical patients with retroperitoneal sarcoma. Radiation therapy for retroperitoneal sarcoma patients is complex because it requires decisions on not only the timing of administration, but also the tec...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328122d757

    authors: Pawlik TM,Ahuja N,Herman JM

    更新日期:2007-07-01 00:00:00

  • Testicular germ cell tumors.

    abstract:PURPOSE OF REVIEW:Preclinical and clinical developments in germ cell tumors over the past year are summarized. RECENT FINDINGS:Attenuations in the rising incidence of testicular germ cell tumors are beginning to be observed in certain European populations. Additional data on predisposing factors related to race, estro...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3280ad43df

    authors: Bridges B,Hussain A

    更新日期:2007-05-01 00:00:00

  • Preclinical studies, experimental therapeutics, and clinical management of advanced melanoma.

    abstract::The preclinical and clinical investigations of therapeutic approaches to melanoma have progressed significantly in the past year. This article reviews recently published information relevant to preclinical studies of the biologic function of stromal tissue, growth factors (and receptors), interferons, cytokines, and a...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199204000-00020

    authors: Kirkwood JM

    更新日期:1992-04-01 00:00:00

  • Molecular prediction of metastasis in cutaneous squamous cell carcinoma.

    abstract:PURPOSE OF REVIEW:Cutaneous squamous cell carcinoma (cSCC) is a highly prevalent malignancy frequently occurring on body surfaces chronically exposed to ultraviolet radiation. While a large majority of tumors remain localized to the skin and immediate subcutaneous tissue and are cured with surgical excision, a small su...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000609

    authors: Mulvaney PM,Schmults CD

    更新日期:2020-03-01 00:00:00

  • Corrupt policemen: inflammatory cells promote tumor angiogenesis.

    abstract:PURPOSE OF REVIEW:The last decade has seen a paradigm change in that tumor stroma contributes to malignant tumor progression in a manner comparable to genetic and epigenetic changes within cancer cells. This review summarizes recent novel insights into how inflammatory conditions stimulate the formation and expansion o...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32831bed7e

    authors: Zumsteg A,Christofori G

    更新日期:2009-01-01 00:00:00

  • Surgical chores and approach in the management of endometrial cancer.

    abstract::Carcinoma of the uterine corpus is the most common malignancy in the female pelvis. Surgical resection and staging are now the accepted approach to therapy, with excellent survival compared with other gynecologic malignancies. Several controversies exist, however, regarding optimal surgical management. Some of these c...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200209000-00007

    authors: McAlpine JN,Spirtos NM,Chen MD

    更新日期:2002-09-01 00:00:00

  • Renal cell carcinoma.

    abstract::The behavior of renal cell carcinoma remains one of the most unpredictable of the genitourinary neoplasms. Once this disease has spread beyond the confines of the kidney, it is extremely difficult to control. This year, emphasis has focused on the characteristic cytogenetic and chromosomal changes that are seen in thi...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199206000-00002

    authors: Reese JH

    更新日期:1992-06-01 00:00:00

  • Thyroid nodules: diagnosis and therapy.

    abstract::Less than 1% of all cancers are present in the thyroid, yet thyroid nodules are found in 4 to 10% of the adult population. Because thyroid nodules are relatively common, the diagnostic dilemma is to distinguish between a more common benign nodule, which usually does not require specific treatment, and a malignant nodu...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200201000-00009

    authors: Weiss RE,Lado-Abeal J

    更新日期:2002-01-01 00:00:00

  • New developments in bone marrow transplantation.

    abstract::A better understanding of the immunobiology after transplantation and of the available recombinant cytokines that enhance hematopoietic reconstitution following autologous and allogeneic bone marrow transplantation is likely to result in safer application of bone marrow transplantation. Residual tumor cells escaping c...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199104000-00005

    authors: Slavin S,Nagler A

    更新日期:1991-04-01 00:00:00

  • Radiotherapy, hyperthermia, and phototherapy for central nervous system tumors.

    abstract::Many new modalities and increasing data have become available in the treatment of brain tumors. We will review the growing experience with newer treatment modalities such as brachytherapy, radiosurgery, hyperthermia, and photodynamic therapy. ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199206000-00015

    authors: Bahary JP,Larson DA

    更新日期:1992-06-01 00:00:00

  • Management of leptomeningeal carcinomatosis and challenges of trial design.

    abstract:PURPOSE OF REVIEW:Highlight recent data in lung and breast cancer leptomeningeal disease and address clinical trials that are open for patients. RECENT FINDINGS:Patients with lung and breast cancer leptomeningeal disease have survival outcomes of less than 1 year, despite advances in treatment strategy. Efforts to dev...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000574

    authors: Gill CM,Brastianos PK

    更新日期:2019-11-01 00:00:00

  • Bisphosphonates in cancer therapy.

    abstract::Bisphosphonates inhibit osteoclast-mediated bone resorption in metastatic bone disease. A wealth of preclinical data have begun to shed light on the complex mechanisms by which bisphosphonates inhibit bone resorption and interfere with the formation and growth of bone metastases. Nitrogen-containing bisphosphonates in...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200211000-00004

    authors: Green JR

    更新日期:2002-11-01 00:00:00

  • Circulating tumor markers in gynecological tumors.

    abstract::The correct use of tumor markers in patients with gynecological cancers can make an impact on management of the disease. Their value in screening for ovarian cancer cannot be recommended outside trials. Increased levels of various markers give prognostic information that could alter therapy for patients with early ova...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199609000-00015

    authors: Rustin GJ

    更新日期:1996-09-01 00:00:00

  • Biologic therapy for lymphoma.

    abstract::Biologic approaches to lymphoma treatment are now a practical reality rather than a vaguely perceived hope for the future. Interferon alfa seems to have been established as a life-extending therapy for selected patients with follicular lymphoma. Humanized anti-CD20 monoclonal antibody (rituximab) has an authentic 50% ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199909000-00005

    authors: Bendandi M,Longo DL

    更新日期:1999-09-01 00:00:00